Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 4

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 4
---
 applicable VWAP Purchase Date beginning at the opening
of trading and ending at the VWAP Purchase Termination Time (as defined in the Purchase Agreement).

At
any time from and after the Commencement Date, on any business day that is also the VWAP Purchase Date for a VWAP Purchase, the Company
may also direct the Purchaser to purchase, on such same business day (the “Additional VWAP Purchase Date”), an additional
number of shares of Depositary Shares in an amount up to the Additional VWAP Purchase Maximum Amount (as defined in the Purchase Agreement)
(an “Additional VWAP Purchase”) at a purchase price equal to the lesser of 95% of (i) the closing price of a Depositary Share
on the trading day immediately prior to such applicable Purchase Date and (ii) the VWAP during the Additional VWAP Purchase Period (as
defined in the Purchase Agreement) on the applicable Additional VWAP Purchase Date.

| 2 |

If
the Company makes certain issuances of Company securities within a specified period of time after a Purchase Date and such securities
are issued at prices (the “New Issuance Price”) less than the prices to be paid by the Purchaser in such Fixed Purchase, VWAP
Purchase or Additional VWAP Purchase, the purchase price for such applicable Fixed Purchase, VWAP Purchase and Additional VWAP Purchase
would be reduced to the New Issuance Price, subject to the terms and conditions set forth in the Purchase Agreement.

Under
the Purchase Agreement, in no event may the aggregate amount of Purchase Shares submitted in any single or combination of VWAP Purchase
notices and/or Additional VWAP Purchase notices on a particular date require a payment from the Purchaser to the Company that exceeds
$2,500,000, unless such limitation is waived by the Purchaser.

In addition, the
Purchaser is not obligated to buy any Ordinary Shares (including Ordinary Shares represented by Depositary Shares) pursuant to the Purchase
Agreement if such Ordinary Shares (including Ordinary Shares represented by Depositary Shares), when aggregated with all other Ordinary
Shares (including Ordinary Shares represented by Depositary Shares) then beneficially owned by the Purchaser and its affiliates (as calculated
pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and Rule 13d-3 promulgated thereunder) following the applicable
purchase by the Purchaser, would result in the Purchaser beneficially owning Ordinary Shares (including Ordinary Shares